期刊文献+

小儿川崎病52例临床分析 被引量:2

Clinical analysis of 52 children with Kawasaki disease
原文传递
导出
摘要 目的探讨小儿川崎病(KD)的诊断及治疗方法。方法对52例KD患儿的临床表现、辅助检查及治疗方法和治疗效果进行回顾性分析。综合性治疗基础上,治疗组(26例)应用丙种球蛋白静脉滴注(IVIG)连续治疗2次,对照组(26例)应用IVIG治疗1次。IVIG治疗无效的患儿应用糖皮质激素治疗。结果小儿KD的诊断主要靠临床表现;治疗组总有效率为92.3%,对照组为69.2%,两组比较差异有统计学意义(P〈0.05);治疗组冠状动脉病变率为0,对照组为19.2%,两组比较差异有统计学意义(P〈0.05);IVIG治疗无效的患儿加用糖皮质激素可缩短发热时间。结论联合应用IVIG和阿司匹林口服是小儿KD的首选治疗方案;IVIG连续应用2次疗效显著,可明显降低冠状动脉病变率;IVIG治疗无效的患儿加用糖皮质激素有一定的疗效。 Objective To investigate the diagnosis and treatment of children with Kawasaki dis- ease(KD). Methods The clinical manifestation, auxiliary examination, treatment methods and treat- ment effects of 52 children with KD were retrospectively analyzed. On the basis of comprehensive treat- ment, the patients in treatment group (26 cases) were treated with intravenous gamma globulin (IVIG)for 2 consecutive times, and the patients in control group (26 cases) were given IVIG for 1 time. The invalid children of IVIG were treated with glucocorticoid. Results The diagnosis of children with KD depended on clinical manifestations ;The total effective rate in the treatment group was 92. 3%, and that in the control group was 69. 2%, there was significant difference(P 〈0. 05) ; Rate of coronary artery lesions in the treat- ment group was 0, and that in the control group was 19. 2%, there was significant difference ( P 〈 0. 05 ) ; The invalid children of IVIG with glucocorticoid could shorten the heating time. Conclusions Combined use of IVIG and oral aspirin is the preferred treatment method for children with KD;the curative effect of IVIG for 2 consecutive times is distinct, which can obviously reduce the rate of coronary artery lesions; the invalid children of IVIG with glucocorticoid has certain curative effect.
作者 吴铭辉
出处 《中国实用医刊》 2014年第9期54-56,共3页 Chinese Journal of Practical Medicine
关键词 小儿 川崎病 临床分析 Infant Kawasaki disease Clinical analysis
  • 相关文献

参考文献10

二级参考文献39

  • 1黄国英,马晓静,黄敏,陈树宝,黄美蓉,邱定忠,过仲珍,蒋瑾瑾,周晓迅,于清,桂永浩,宁寿葆,张拓红,杜忠东,Hiroshi Yanagawa,Tomisaku Kawasaki.上海地区1998-2002年川崎病流行病学特征[J].中国循证儿科杂志,2006,1(1):8-13. 被引量:63
  • 2覃丽君,王宏伟,胡秀芬,刘清军,施虹,隈远祥,陈全景,程佩萱.静脉注射不同剂量丙种球蛋白治疗川崎病的临床研究[J].中华儿科杂志,2006,44(12):891-895. 被引量:39
  • 3崔喜英,帅金凤.以肝损害为首发表现的川崎病并巨大冠状动脉瘤1例[J].实用儿科临床杂志,2007,22(1):28-28. 被引量:6
  • 4Du ZD, Zhang T, Ling L, et al. Epidemiologic picture of Kawasa- ki disease in Beijing from 1995 through 1999 [J]. Pediatr Infect Dis J,2002,2(2) : 103-107.
  • 5Du ZD, Zhao D, Du JB, et al. Epidemiologic study on Kawasaki disease in Beijing fiom 2000 through 2004 [J]. Pediatr Infect Dis J,2007,26:12-15.
  • 6Newhurger JW, Takahashi M, Gerher MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statemenl for health professionals from the Committee on Rheu- matic: Fever, Endoearditis. and Kawasaki Disease, Council on CardiovaseularDisease in the Young, American Heart Associa- tion[J]. Pediatrics, 2004,114: 1708-1733.
  • 7Dajani AS, Tauberl KA, Gerber MA, et al. special report : diag- nosis and therapy of Kawasaki disease in ehildren [J]. Cireula- titan, 1993,87 (5) :1776-1780.
  • 8Gibbons RJ, Beasley JW. ACC/AHA 2002 guideline update for exercise testing: a report of the american college of Cardiology / American hearl Association Task Force on Practice Guidelines [J]. J Am Coll Cardiol,2002,40:15311540.
  • 9Japanese Circulation Soeiety Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Ka- wasaki disease [ J ]. Pediatr Int, 2005,47 : 711-732.
  • 10Hirata S, Nakamura Y, Yanagawa H. Incidence rate of reeurrent Kawasaki disease and related risk factors: from the results of na- tionwide surveys of Kawasaki disease in Japan [J ]. Acta Pediatr, 2001,90( 1 ):40.

共引文献187

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部